Literature DB >> 11134353

Jak3 selectively regulates Bax and Bcl-2 expression to promote T-cell development.

R Wen1, D Wang, C McKay, K D Bunting, J C Marine, E F Vanin, G P Zambetti, S J Korsmeyer, J N Ihle, J L Cleveland.   

Abstract

Jak3-deficient mice display vastly reduced numbers of lymphoid cells. Thymocytes and peripheral T cells from Jak3-deficient mice have a high apoptotic index, suggesting that Jak3 provides survival signals. Here we report that Jak3 regulates T lymphopoiesis at least in part through its selective regulation of Bax and Bcl-2. Jak3-deficient thymocytes express elevated levels of Bax and reduced levels of Bcl-2 relative to those in wild-type littermates. Notably, up-regulation of Bax in Jak3-deficient T cells is physiologically relevant, as Jak3 Bax double-null mice have marked increases in thymocyte and peripheral T-cell numbers. Rescue of T lymphopoiesis by Bax loss was selective, as mice deficient in Jak3 plus p53 or in Jak3 plus Fas remained lymphopenic. However, Bax loss failed to restore proper ratios of peripheral CD4/CD8 T cells, which are abnormally high in Jak3-null mice. Transplantation into Jak3-deficient mice of Jak3-null bone marrow transduced with a Bcl-2-expressing retrovirus also improved peripheral T-cell numbers and restored the ratio of peripheral CD4/CD8 T cells to wild-type levels. The data support the concepts that Jak kinases regulate cell survival through their selective and cell context-dependent regulation of pro- and antiapoptotic Bcl-2 family proteins and that Bax and Bcl-2 play distinct roles in T-cell development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134353      PMCID: PMC86650          DOI: 10.1128/MCB.21.2.678-689.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  68 in total

1.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.

Authors:  W E Thierfelder; J M van Deursen; K Yamamoto; R A Tripp; S R Sarawar; R T Carson; M Y Sangster; D A Vignali; P C Doherty; G C Grosveld; J N Ihle
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

2.  Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis.

Authors:  Y T Hsu; K G Wolter; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

4.  Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality.

Authors:  K Takeda; K Noguchi; W Shi; T Tanaka; M Matsumoto; N Yoshida; T Kishimoto; S Akira
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice.

Authors:  E Maraskovsky; L A O'Reilly; M Teepe; L M Corcoran; J J Peschon; A Strasser
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

6.  Mutations in the p53 and SCID genes cooperate in tumorigenesis.

Authors:  M Nacht; A Strasser; Y R Chan; A W Harris; M Schlissel; R T Bronson; T Jacks
Journal:  Genes Dev       Date:  1996-08-15       Impact factor: 11.361

7.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice.

Authors:  M H Kaplan; Y L Sun; T Hoey; M J Grusby
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

8.  Stat5a is mandatory for adult mammary gland development and lactogenesis.

Authors:  X Liu; G W Robinson; K U Wagner; L Garrett; A Wynshaw-Boris; L Hennighausen
Journal:  Genes Dev       Date:  1997-01-15       Impact factor: 11.361

9.  Bax suppresses tumorigenesis and stimulates apoptosis in vivo.

Authors:  C Yin; C M Knudson; S J Korsmeyer; T Van Dyke
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

10.  bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.

Authors:  M E McCurrach; T M Connor; C M Knudson; S J Korsmeyer; S W Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

View more
  15 in total

1.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

Review 2.  A survival guide to early T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Protein kinase C-theta is required for efficient positive selection.

Authors:  Sharon Celeste Morley; K Scott Weber; Henry Kao; Paul M Allen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

4.  Bax regulates neuronal Ca2+ homeostasis.

Authors:  Beatrice D'Orsi; Seán M Kilbride; Gang Chen; Sergio Perez Alvarez; Helena P Bonner; Shona Pfeiffer; Nikolaus Plesnila; Tobias Engel; David C Henshall; Heiko Düssmann; Jochen H M Prehn
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

5.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

6.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

7.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.

Authors:  Joji Nakayama; Mutsumi Yamamoto; Katsuhiko Hayashi; Hitoshi Satoh; Kenji Bundo; Masato Kubo; Ryo Goitsuka; Michael A Farrar; Daisuke Kitamura
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

8.  An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion.

Authors:  Renren Wen; Yuhong Chen; James Schuman; Guoping Fu; Shoua Yang; Weiguo Zhang; Debra K Newman; Demin Wang
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

9.  Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models.

Authors:  Melanie G Cornejo; Michael G Kharas; Miriam B Werneck; Séverine Le Bras; Sandra A Moore; Brian Ball; Marie Beylot-Barry; Scott J Rodig; Jon C Aster; Benjamin H Lee; Harvey Cantor; Jean-Philippe Merlio; D Gary Gilliland; Thomas Mercher
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.